🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/10/1988 | 9,14 | 9,28 | 9,14 | 9,22 | -0,43% | 1,52% | 3.354.019 |
| 17/10/1988 | 9,30 | 9,34 | 9,20 | 9,26 | -0,85% | 1,50% | 2.382.523 |
| 14/10/1988 | 9,34 | 9,38 | 9,18 | 9,34 | +0,64% | 2,13% | 3.785.376 |
| 13/10/1988 | 9,12 | 9,30 | 9,12 | 9,28 | +1,30% | 1,96% | 2.443.517 |
| 12/10/1988 | 9,26 | 9,30 | 9,12 | 9,16 | -2,54% | 1,93% | 4.783.910 |
| 11/10/1988 | 9,38 | 9,40 | 9,30 | 9,40 | -0,42% | 1,06% | 2.694.408 |
| 10/10/1988 | 9,42 | 9,46 | 9,38 | 9,44 | -0,21% | 0,84% | 3.400.550 |
| 07/10/1988 | 9,32 | 9,48 | 9,28 | 9,46 | +2,15% | 2,13% | 7.494.038 |
| 06/10/1988 | 9,16 | 9,26 | 9,10 | 9,26 | +1,08% | 1,74% | 3.537.000 |
| 05/10/1988 | 9,18 | 9,20 | 9,12 | 9,16 | +0,22% | 0,87% | 3.208.766 |
| 04/10/1988 | 9,16 | 9,22 | 9,12 | 9,14 | +0,44% | 1,08% | 3.581.645 |
| 03/10/1988 | 9,22 | 9,24 | 9,05 | 9,10 | -0,87% | 2,16% | 3.865.862 |
| 30/09/1988 | 9,30 | 9,38 | 9,18 | 9,18 | -1,49% | 2,14% | 5.160.562 |
| 29/09/1988 | 9,20 | 9,36 | 9,18 | 9,32 | +1,73% | 1,94% | 6.553.982 |
| 28/09/1988 | 9,08 | 9,16 | 9,06 | 9,16 | +0,66% | 1,09% | 2.514.571 |
| 27/09/1988 | 9,08 | 9,10 | 9,01 | 9,10 | +0,22% | 1,09% | 1.915.954 |
| 26/09/1988 | 9,10 | 9,12 | 9,05 | 9,08 | -0,44% | 0,87% | 1.565.083 |
| 23/09/1988 | 9,12 | 9,14 | 9,01 | 9,12 | -0,22% | 1,53% | 2.947.186 |
| 22/09/1988 | 9,30 | 9,32 | 9,12 | 9,14 | -1,71% | 2,14% | 5.394.475 |
| 21/09/1988 | 9,26 | 9,36 | 9,20 | 9,30 | +1,30% | 1,72% | 8.377.502 |
| 20/09/1988 | 9,20 | 9,22 | 9,16 | 9,18 | +0,00% | 0,65% | 2.678.059 |
| 19/09/1988 | 9,28 | 9,28 | 9,16 | 9,18 | -1,49% | 1,29% | 3.584.160 |
| 16/09/1988 | 9,22 | 9,36 | 9,20 | 9,32 | +0,86% | 1,72% | 8.967.946 |
| 15/09/1988 | 9,30 | 9,36 | 9,22 | 9,24 | -0,64% | 1,50% | 5.112.144 |
| 14/09/1988 | 9,26 | 9,32 | 9,22 | 9,30 | +1,30% | 1,07% | 5.802.566 |
| 13/09/1988 | 9,18 | 9,20 | 9,10 | 9,18 | +0,00% | 1,08% | 4.154.482 |
| 12/09/1988 | 9,18 | 9,24 | 9,12 | 9,18 | +0,00% | 1,30% | 5.634.677 |
| 09/09/1988 | 9,05 | 9,22 | 8,97 | 9,18 | +1,54% | 2,86% | 4.542.451 |
| 08/09/1988 | 9,03 | 9,08 | 9,01 | 9,05 | +0,00% | 0,88% | 3.631.320 |
| 07/09/1988 | 8,99 | 9,05 | 8,95 | 9,05 | +0,89% | 1,11% | 4.011.115 |